We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First-Of-Its-Kind 4K Endoscope for Arthroscopic Surgical Procedures Launched Globally

By HospiMedica International staff writers
Posted on 07 Nov 2022

A first-of-its-kind 4K endoscope designed for use in arthroscopic surgical procedures is revolutionizing the market by delivering 4K optics in a single-use device – providing first-time quality for every procedure. More...

Integrated Endoscopy (Irvine, CA, USA) has launched its second generation NUVIS (pronounced “nu-vee”) Single-Use Arthroscope, a first-of-its-kind 4K endoscope designed for use in arthroscopic surgical procedures. The release of the Gen II NUVIS features a patent pending simplified optical train design which reduces the number of optical elements by over 60% while boosting image quality to 4K. Not only is the image quality superior, but the Gen II NUVIS will also be substantially faster and less expensive to manufacture and amenable to high-volume automation.

As part of the Gen II launch, Integrated Endoscopy is releasing multiple versions of NUVIS to make the technology compatible with most cannulas on the market. NUVIS is also compatible with most installed video towers and will support a 4K camera system without requiring additional capital equipment. NUVIS has a built-in battery powered LED, which eliminates the light box and bulky light cord. Integrated Endoscopy’s Gen II NUVIS single-use, 4K, battery operated cordless arthroscope is FDA 501(k) cleared, CE marked, and is being registered in a number of markets around the world. As manufacturing capacity increases, the company will continue to expand its global distribution network to provide this unique technology to the arthroscopic surgical community.

“The release of the Gen II NUVIS is a huge milestone for the company in terms of image quality and compatibility,” said Brad Sharp, Integrated Endoscopy’s CEO. “Our next-gen arthroscope also provides a substantial decrease in manufacturing costs while simultaneously increasing ease of manufacturability. The demand we have seen for NUVIS far exceeds our current manufacturing capacity, so the efficiencies the Gen II NUVIS affords will greatly aid in shortening production time and costs. With a global market of over 1.5 million units per month, increasing our manufacturing capacity will be a major focus for the company moving forward.”

Related Links:

Integrated Endoscopy


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.